VIQ Solutions Reports Fourth Quarter and Full Year 2022 Financial Results
VIQ Solutions Inc. (VQS) reported a 48% year-over-year revenue increase for 2022, reaching $45.8 million, with 93% identified as Annual Recurring Revenue (ARR). The fourth quarter saw revenue rise to $10.2 million, up 35%, while gross profit increased by 45% to $4.8 million. Despite these gains, the company posted a net loss of $8.7 million for the year, although this shows a significant improvement over the prior year. VIQ recently secured a $15 million senior debt facility to enhance liquidity and support growth. The company continues to face compliance risks with Nasdaq's pricing rule, needing to maintain a stock price above $1.00 by September 25, 2023.
- 48% revenue growth in 2022, reaching $45.8 million.
- 93% of revenue classified as Annual Recurring Revenue (ARR).
- Fourth quarter revenue increased 35% year-over-year.
- Net loss for 2022 was $8.7 million, but improved from $19.7 million the previous year.
- Adjusted EBITDA of negative $3.4 million for 2022, a 31% decline.
- Compliance risk with Nasdaq due to stock price falling below $1.00.
“We ended a challenging 2022 with a
“The positive impact our AI-powered, NetScribe™ technology has had in our most mature markets was impressive and underscores the value of VIQ IP. Productivity and efficiency gains reflected in gross margin post migration reached
Fourth Quarter 2022 Financial Highlights
-
Revenue of
, an increase of$10.2 million , or$2.7 million 35% , from the same period in the prior year. -
Gross profit of
, an increase of$4.8 million , or$1.5 million 45% , from the same period in the prior year. -
Net loss of
, a decrease of$2.2 million , from the same period in the prior year.$1.5 million -
Adjusted EBITDA of negative
, a decrease of$1.2 million , or$0.6 million 35% , from the same period in the prior year.
Full Year 2022 Financial Highlights
-
Revenue of
, an increase of$45.8 million , or$14.8 million 48% , from the same period in the prior year. -
Gross profit of
, an increase of$21.9 million , or$7.0 million 47% , from the same period in the prior year. -
Net loss of
, a decrease of$8.7 million , or$11.0 million 56% , for the same period in the prior year. -
Adjusted EBITDA1 was negative
, a decrease$3.4 million , or$1.5 million 31% from the same period in the prior year.
1 Represents a non-IFRS measure. Please refer to the "Non-IFRS Measures" section below and the reconciliation tables at the end of this press release.
On
“As macroeconomic headwinds changed, we adjusted our focus, aligning our global resources, conducting a
Nasdaq
As previously disclosed, on
On
Conference Call Details
VIQ will host a conference call and webcast to discuss its fourth quarter and full year 2022 financial results on
Investors may access a live webcast of the call on the Company’s website at www.viqsolutions.com/investors or by dialing 1-888-440-4052 (
A replay of the webcast will be available on the Company’s website through the same link approximately one hour after the conference call concludes.
For more information about VIQ, please visit viqsolutions.com.
About
Forward-looking Statements
Certain statements included in this press release constitute forward-looking statements or forward-looking information (collectively, “forward-looking statements”) under applicable securities legislation. Such forward-looking statements or information are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes.
Forward-looking statements (typically contain statements with words such as "anticipate", "believe", "expect", "plan", "intend", "estimate", "propose", "project" or similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions “may” or “will” occur. These statements are only predictions. Forward-looking statements in this press release include, but are not limited to statements with respect to the Company’s strategy, improvements to margins, benefits of the Beedie facility, expectations around the Nasdaq delisting and the conference call to discuss the Company’s fourth quarter and full year 2022 results.
Forward-looking statements is based on several factors and assumptions which have been used to develop such statements, but which may prove to be incorrect. Although VIQ believes that the expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on forward-looking statements because VIQ can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding, among other things, recent initiatives and that sales and prospects may increase revenue. Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions that have been used.
Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements, including but not limited to the factors described in greater detail in the “Risk Factors” section of the Company’s annual report form on SEC Form 20-F form dated
These factors are not intended to represent a complete list of the factors that could affect the Company, however, these factors should be considered carefully. Such estimates and assumptions may prove to be incorrect or overstated. The forward-looking statements contained in this press release are made as of the date of this press release and the Company expressly disclaims any obligations to update or alter such statements or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
(Expressed in |
||||||||||||||||
|
Three months ended
|
Period over Period Change |
Year ended
|
Period over Period Change |
||||||||||||
|
2022 |
2021 |
$ |
% |
2022 |
2021 |
$ |
% |
||||||||
Revenue |
10,181,580 |
7,514,421 |
2,667,159 |
35 |
45,843,929 |
31,046,812 |
14,797,117 |
48 |
||||||||
Cost of sales |
5,416,313 |
4,232,474 |
1,183,839 |
28 |
23,918,226 |
16,123,853 |
7,794,373 |
48 |
||||||||
Gross profit |
4,765,267 |
3,281,947 |
1,483,320 |
45 |
21,925,703 |
14,922,959 |
7,002,744 |
47 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Expenses |
|
|
|
|
|
|
|
|
||||||||
Selling and administrative expenses |
5,897,545 |
5,111,108 |
786,437 |
15 |
24,526,303 |
19,119,713 |
5,406,590 |
28 |
||||||||
Research and development expenses |
91,824 |
274,889 |
(183,065) |
(67) |
734,115 |
1,092,108 |
(357,993) |
(33) |
||||||||
Loss (Gain) on contingent consideration |
(27,808) |
(265,592) |
237,784 |
(90) |
80,071 |
(332,569) |
412,640 |
(124) |
||||||||
Stock-based compensation |
605,343 |
862,283 |
(256,940) |
(30) |
2,779,312 |
8,495,189 |
(5,715,877) |
(67) |
||||||||
Depreciation |
146,766 |
67,707 |
79,059 |
117 |
579,249 |
257,099 |
322,150 |
125 |
||||||||
Amortization |
2,289,819 |
1,102,465 |
1,187,354 |
108 |
5,508,954 |
4,384,502 |
1,124,452 |
26 |
||||||||
Interest expense |
236,885 |
334,489 |
(97,604) |
(29) |
1,052,618 |
1,331,100 |
(278,482) |
(21) |
||||||||
Accretion and other financing costs |
475,598 |
211,136 |
264,462 |
125 |
1,231,194 |
967,106 |
264,088 |
27 |
||||||||
Loss on extinguishment of debt |
- |
- |
- |
100 |
747,865 |
- |
747,865 |
100 |
||||||||
Gain on revaluation of options |
(447,737) |
(526,081) |
78,344 |
(15) |
(1,511,399) |
(1,028,055) |
(483,344) |
47 |
||||||||
Gain on revaluation of RSUs |
(104,578) |
(123,583) |
19,005 |
(15) |
(550,260) |
(242,595) |
(307,665) |
127 |
||||||||
Gain on revaluation of the derivative warrant liability |
(730,491) |
(604,681) |
(125,810) |
21 |
(4,255,017) |
(1,368,180) |
(2,886,837) |
211 |
||||||||
Restructuring Costs |
19,385 |
37,378 |
(17,992) |
(48) |
323,075 |
432,702 |
(109,627) |
(25) |
||||||||
Impairment of PPE |
15,246 |
- |
15,246 |
100 |
15,246 |
- |
15,246 |
100 |
||||||||
Business acquisition costs |
14,516 |
356,410 |
(341,895) |
(96) |
433,372 |
539,734 |
(106,362) |
(20) |
||||||||
Other income |
(392) |
(1,483) |
1,091 |
(74) |
(1,291) |
(12,003) |
10,712 |
(89) |
||||||||
Foreign exchange (gain) loss |
(1,049,277) |
99,382 |
(1,148,659) |
1,156 |
(452,068) |
22,130 |
(474,198) |
(2,143) |
||||||||
Loss before income taxes |
(2,667,377) |
(3,653,880) |
986,503 |
27 |
(9,315,636) |
(18,735,022) |
9,419,386 |
50 |
||||||||
Current income tax recovery (expense) |
180,071 |
(40,329) |
220,400 |
(547) |
105,256 |
875 |
104,381 |
11,929 |
||||||||
Deferred income tax recovery (expense) |
319,284 |
40,416 |
278,868 |
690 |
504,365 |
(944,602) |
1,448,967 |
(153) |
||||||||
Income tax recovery (expense) |
499,355 |
87 |
499,268 |
(573,871) |
609,621 |
(943,727) |
1,553,348 |
165 |
||||||||
Net Loss |
(2,168,022) |
(3,653,793) |
1,485,771 |
41 |
(8,706,015) |
(19,678,749) |
10,972,734 |
56 |
||||||||
Adjusted EBITDA (1) |
(1,196,294) |
(1,838,458) |
642,163 |
35 |
(3,414,786) |
(4,956,293) |
1,541,507 |
31 |
||||||||
|
|
|
|
|
|
|
|
|
||||||||
Weighted average number of common shares outstanding |
|
|
|
|
||||||||||||
Basic |
23,061,227 |
29,880,185 |
|
|
31,648,001 |
26,448,594 |
|
|
||||||||
Diluted |
23,061,227 |
29,880,185 |
|
|
31,648,001 |
26,448,594 |
|
|
||||||||
Net income (loss) per share |
|
|
|
|
|
|
|
|
||||||||
Basic |
(0.09) |
(0.12) |
|
|
(0.28) |
(0.74) |
|
|
||||||||
Diluted |
(0.09) |
(0.12) |
|
|
(0.28) |
(0.74) |
||||||||||
1Adjusted EBITDA is earnings before stock-based compensation, depreciation, amortization, interest expense, accretion and other financing expense, loss on extinguishment of debt, gain on revaluation of options, RSUs, and derivative warrant liability, restructuring costs, impairment of PPE, business acquisition costs, other income, foreign exchange (gain) loss, and current and deferred income tax expense (recovery), is a non-IFRS measure. Please refer to the section entitled “Non-IFRS Measures.” |
Consolidated Statements of Financial Position
(Expressed in |
||||||||
|
|
(Restated) |
||||||
Assets |
|
|
||||||
Current assets |
|
|
||||||
Cash |
$ |
1,657,571 |
|
$ |
10,583,534 |
|
||
Trade and other receivables, net of allowance for doubtful accounts |
|
5,305,728 |
|
|
5,594,368 |
|
||
Income tax recoverable |
|
104,670 |
|
|
– |
|
||
Inventories |
|
37,807 |
|
|
49,557 |
|
||
Prepaid expenses and deposits |
|
2,050,661 |
|
|
2,054,793 |
|
||
Non-current assets |
|
9,156,437 |
|
|
18,282,252 |
|
||
Restricted cash |
|
463,743 |
|
|
303,945 |
|
||
Property and equipment |
|
1,432,133 |
|
|
460,974 |
|
||
Right-of-use assets, net |
|
1,058,600 |
|
|
1,134,493 |
|
||
Intangible assets, net |
|
10,731,917 |
|
|
14,928,984 |
|
||
|
|
12,047,048 |
|
|
12,440,557 |
|
||
Deferred tax assets |
|
655,004 |
|
|
464,800 |
|
||
Total assets |
$ |
35,544,882 |
|
$ |
48,016,005 |
|
||
Liabilities |
|
|
||||||
Current liabilities |
|
|
||||||
Trade and other payables and accrued liabilities |
$ |
5,937,880 |
|
$ |
5,679,628 |
|
||
Income tax payable |
|
45,212 |
|
|
97,784 |
|
||
Share-based payment liability |
|
31,487 |
|
|
551,201 |
|
||
Derivative warrant liability |
|
290,712 |
|
|
1,862,876 |
|
||
Current portion of long-term debt |
|
8,634,258 |
|
|
1,109,713 |
|
||
Current portion of lease obligations |
|
487,673 |
|
|
287,901 |
|
||
Contract liabilities |
|
1,745,415 |
|
|
1,003,187 |
|
||
Non-current liabilities |
|
17,172,637 |
|
|
10,592,290 |
|
||
Deferred tax liability |
|
868,643 |
|
|
1,224,640 |
|
||
Long-term debt |
|
19,812 |
|
|
11,999,108 |
|
||
Long-term contingent consideration |
|
– |
|
|
166,603 |
|
||
Long-term lease obligations |
|
718,575 |
|
|
900,868 |
|
||
Other long-term liabilities |
|
1,121,805 |
|
|
1,042,938 |
|
||
Total liabilities |
|
19,901,472 |
|
|
25,926,447 |
|
||
Shareholders' Equity |
|
|
||||||
Capital stock |
|
74,690,527 |
|
|
72,191,764 |
|
||
Contributed surplus |
|
5,892,192 |
|
|
4,842,208 |
|
||
Accumulated other comprehensive income (loss) |
|
(1,214,354 |
) |
|
74,526 |
|
||
Deficit |
|
(63,724,955 |
) |
|
(55,018,940 |
) |
||
Total shareholders’ equity |
|
15,643,410 |
|
|
22,089,558 |
|
||
Total liabilities and shareholders' equity |
$ |
35,544,882 |
|
$ |
48,016,005 |
|
Consolidated Statements of Loss and Comprehensive Loss
(Expressed in |
||||||||
|
Year ended |
|||||||
|
|
2022 |
|
|
2021 |
|
||
Revenue |
$ |
45,843,929 |
|
$ |
31,046,812 |
|
||
|
|
|
||||||
Cost of sales |
|
23,918,226 |
|
|
16,123,853 |
|
||
Gross profit |
|
21,925,703 |
|
|
14,922,959 |
|
||
|
|
|
||||||
Expenses |
|
|
||||||
Selling and administrative expenses |
|
24,526,303 |
|
|
19,119,713 |
|
||
Research and development expenses |
|
734,115 |
|
|
1,092,108 |
|
||
Stock-based compensation |
|
2,779,312 |
|
|
8,495,189 |
|
||
Gain on revaluation of options |
|
(1,511,399 |
) |
|
(1,028,055 |
) |
||
Gain on revaluation of RSUs |
|
(550,260 |
) |
|
(242,595 |
) |
||
Gain on revaluation of the derivative warrant liability |
|
(4,255,017 |
) |
|
(1,368,180 |
) |
||
Foreign exchange loss (gain) |
|
(452,068 |
) |
|
22,130 |
|
||
Depreciation |
|
579,249 |
|
|
257,099 |
|
||
Amortization |
|
5,508,954 |
|
|
4,384,502 |
|
||
Interest expense |
|
1,052,618 |
|
|
1,331,100 |
|
||
Accretion and other financing costs |
|
1,231,194 |
|
|
967,106 |
|
||
Loss (gain) on contingent consideration |
|
80,071 |
|
|
(332,569 |
) |
||
Loss on revaluation of conversion feature liability |
|
– |
|
|
– |
|
||
Loss on repayment of long-term debt |
|
– |
|
|
– |
|
||
Loss on extinguishment of debt |
|
747,865 |
|
|
– |
|
||
Impairment of goodwill and intangible assets |
|
– |
|
|
– |
|
||
Impairment of property and equipment |
|
15,246 |
|
|
– |
|
||
Restructuring costs |
|
323,075 |
|
|
432,702 |
|
||
Business acquisition costs |
|
433,372 |
|
|
539,734 |
|
||
Other income |
|
(1,291 |
) |
|
(12,003 |
) |
||
Total expenses |
|
31,241,339 |
|
|
33,657,981 |
|
||
|
|
|
||||||
Current income tax (recovery) expense |
|
(105,256 |
) |
|
(875 |
) |
||
Deferred income tax (recovery) expense |
|
(504,365 |
) |
|
944,602 |
|
||
Income tax (recovery) expense |
|
(609,621 |
) |
|
943,727 |
|
||
Net loss for the year |
$ |
(8,706,015 |
) |
$ |
(19,678,749 |
) |
||
Exchange gain (loss) on translating foreign operations |
|
(1,288,880 |
) |
|
153,432 |
|
||
Comprehensive loss for the year |
$ |
(9,994,895 |
) |
$ |
(19,525,317 |
) |
||
|
|
|
||||||
Net loss per share |
|
|
||||||
Basic |
|
(0.28 |
) |
|
(0.74 |
) |
||
Diluted |
|
(0.28 |
) |
|
(0.74 |
) |
||
Weighted average number of common shares outstanding - basic |
|
31,648,001 |
|
|
26,448,594 |
|
||
Weighted average number of common shares outstanding - diluted |
|
31,648,001 |
|
|
26,448,594 |
|
Reconciliation of Non-IFRS Measures
(Expressed in
The following is a reconciliation of Net Loss to Adjusted EBITDA, the most directly comparable IFRS measure for the periods ended |
|||||
|
Three months ended
|
|
Year ended
|
||
(Unaudited) |
2022 |
2021 |
|
2022 |
2021 |
Net Loss |
(2,168,022) |
(3,653,793) |
|
(8,706,015) |
(19,678,749) |
Add: |
|
|
|
|
|
Depreciation |
146,766 |
67,707 |
|
579,249 |
257,099 |
Amortization |
2,289,819 |
1,102,465 |
|
5,508,954 |
4,384,502 |
Interest expense |
236,885 |
334,489 |
|
1,052,618 |
1,331,100 |
Current income tax (recovery) expense |
(180,071) |
40,329 |
|
(105,256) |
(875) |
Deferred income tax (recovery) expense |
(319,284) |
(40,416) |
|
(504,365) |
944,602 |
EBITDA |
6,093 |
(2,149,219) |
|
(2,174,815) |
(12,762,321) |
Accretion and other financing costs |
475,598 |
211,136 |
|
1,231,194 |
967,106 |
Loss on repayment of long-term debt |
- |
- |
|
747,865 |
- |
Gain on revaluation of options |
(447,737) |
(526,081) |
|
(1,511,399) |
(1,028,055) |
Gain on revaluation of RSUs |
(104,578) |
(123,583) |
|
(550,260) |
(242,595) |
Gain on revaluation of the derivative warrant liability |
(730,491) |
(604,681) |
|
(4,255,017) |
(1,368,180) |
Impairment of property and equipment |
15,246 |
- |
|
15,246 |
- |
Restructuring costs |
19,385 |
37,378 |
|
323,075 |
432,702 |
Business acquisition financing costs |
14,516 |
356,410 |
|
433,372 |
539,734 |
Other income |
(392) |
(1,483) |
|
(1,291) |
(12,003) |
Stock-based compensation |
605,343 |
862,283 |
|
2,779,312 |
8,495,189 |
Foreign exchange (gain) loss |
(1,049,277) |
99,382 |
|
(452,068) |
22,130 |
|
|
|
|
|
|
Adjusted EBITDA |
(1,196,294) |
(1,838,458) |
|
(3,414,786) |
(4,956,293) |
The following is a reconciliation of Technology Services, Support and Maintenance, SaaS and Subscription revenue to ARR, the most directly comparable IFRS measure for the periods ended
At
|
|
2022 |
|
Technology Services |
|
41,812,479 |
|
Support & Maintenance |
|
1,872,620 |
|
SaaS |
|
89,692 |
|
Subscription |
|
493,845 |
|
Add: Client Adjustments |
|
(1,532,468 |
) |
Total Annual Recurring Revenue |
$ |
42,736,168 |
|
At
|
|
2021 |
|
Technology Services |
|
26,676,738 |
|
Support & Maintenance |
|
1,772,203 |
|
SaaS |
|
65,187 |
|
Subscription |
|
189,359 |
|
Add: The Transcription Agency Revenue |
|
1,083,415 |
|
Add: Auscript Revenue |
|
10,163,719 |
|
Add: Client Adjustments |
|
8,684,589 |
|
Total Annual Recurring Revenue |
$ |
48,635,210 |
Non-IFRS Measures
The Company prepares its financial statements in accordance with IFRS. Non-IFRS measures are used by management to provide additional insight into our performance and financial condition. We believe non-IFRS measures are an important part of the financial reporting process and are useful in communicating information that complements and supplements the consolidated financial statements. Adjusted EBITDA and ARR are not a measure recognized by IFRS and does not have standardized meanings prescribed by IFRS. Therefore, Adjusted EBITDA and ARR may not be comparable to similar measures presented by other issuers. Investors are cautioned that Adjusted EBITDA should not be construed as an alternative to net income (loss) as determined in accordance with IFRS.
This news release also includes certain measures which have not been prepared in accordance with IFRS such as Adjusted EBITDA. To evaluate the Company’s operating performance as a complement to results provided in accordance with IFRS, the term “Adjusted EBITDA” refers to net income (loss) before earnings for stock-based compensation, depreciation, amortization, interest expense, accretion and other financing expense, (gain) loss on revaluation of options, (gain) loss on revaluation of restricted share units, gain (loss) on revaluation of derivative warrant liability, restructuring costs, (gain) loss on revaluation of conversion feature liability, loss on repayment of long-term debt, business acquisition costs, impairment of goodwill and intangibles, other expense (income), foreign exchange (gain) loss, current and deferred income tax expense. We believe that the items excluded from Adjusted EBITDA are not connected to and do not represent the operating performance of the Company.
We believe that Adjusted EBITDA is useful supplemental information as it provides an indication of the results generated by the Company’s main business activities prior to taking into consideration how those activities are financed and taxed as well as expenses related to stock-based compensation, depreciation, amortization, impairment of goodwill and intangibles, other expense (income), and foreign exchange (gain) loss. Accordingly, we believe that this measure may also be useful to investors in enhancing their understanding of the Company’s operating performance.
ARR is the annualized equivalent value of the 1- Software Support Maintenance (SSM), 2- Software Subscriptions 3- SaaS and 4- Technology Services revenue of all existing contracts as of the date being measured. This excludes non-recurring revenue from implementation, support, and maintenance fees. The majority of our Editing Services contracts are volumes based. Accordingly, our calculation of ARR assumes that the clients will renew the contractual commitments on a periodic basis as those commitments come up for renewal. A portion of the contract renewals are through a competitive tender process. Contracts agreements may be subject to contract value increases upon renewal reflecting both inflationary increases and the additional value and added products and services provided by our solutions. ARR is not adjusted for the impact of any projected future client cancellations, loss of renewals, service upgrades or downgrades or price increases or decreases.
We use ARR as a measure of our revenue trend and an indicator of our future revenue opportunity from existing recurring client contracts.
We believe that this measure provides a fair real-time measure of performance in a volume and subscription-based environment. ARR provides us with the visibility for consistent and predictable growth to our cash flows. Our total revenue growth coupled with increasing ARR indicates the continued strength in the expansion of our business and will continue to be our focus on a go-forward basis.
Trademarks
This press release includes trademarks, such as “aiAssist”, “NetScribe” and “FirstDraft”, which are protected under applicable intellectual property laws and are the property of VIQ. Solely for convenience, our trademarks referred to in this news release may appear without the ® or TM symbol, but such references are not intended to indicate, in any way, that we will not assert our rights to these trademarks, trade names and services marks to the fullest extent under applicable law. Trademarks which may be used in this press release, other than those that belong to VIQ, are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230329005985/en/
Media:
Chief Marketing Officer
Phone: (800) 263-9947
Email: marketing@viqsolutions.com
Investor Relations:
High Touch Investor Relations
Phone: 1-914-598-7733
Email: viq@htir.net
Source:
FAQ
What were VIQ Solutions' financial results for Q4 2022?
What is VIQ Solutions' net loss for 2022?
What is VQS's current compliance status with Nasdaq?
How has VIQ Solutions' revenue changed in 2022?